GlycosBio, Inc.

GlycosBio, Inc. is a biotechnology startup based in the United States. Founded in 2007, the company focuses on research and development to improve the delivery and performance of natural bioactive molecules to the body using plant-based single-solution lipid absorption technologies. Operating from the Johnson & Johnson Innovation Center at the Texas Medical Center, GlycosBio collaborates with scientists and the medical community to design functional solutions for diseases where the microbiome is impaired.

The company's mission is to nourish and enhance the lives of people at all stages of life, particularly focusing on fragile populations struggling with microbiome dysbiosis. Their scientists are working on plant-based alternatives to reduce the dependence on antibiotics and prescription medication, aiming to modernize and elevate nutrition, skincare, and pulmonary health for all populations from infants to adults using clean technology and clinically driven results.

GlycosBio, Inc. recently received a $1.13M Venture Round investment on 06 March 2024. The company's approach to personalized care for a healthy microbiome, in addition to their collaboration with the medical community, demonstrates potential for future growth and impact in the biotechnology and renewable energy industries.